September 8, 2026
Employers are facing an increasingly difficult benefits decision as demand for GLP-1 drugs grows: absorb the rapidly rising cost, restrict coverage or find another way to […]
January 27, 2026
Employers grappling with the cost and complexity of GLP-1 drugs are increasingly testing a workaround: steering certain employees to direct-to-consumer (DTC) arrangements that operate outside the […]
April 15, 2025
Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity and Wegovy, into their group health plans, as they must […]